Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Barnes, J. A. Van Noord, C. Brindicci, L. Lindemann, G. Varoli, M. Perpina, D. Guastalla, D. Casula, P. Chanez (London, United Kingdom; Heerlen, Netherlands; Parma, Italy; Gelsenkirchen, Germany; Valencia, Spain; Marseille, France). Maintenance of lung function and asthma control with extrafine beclomethasone/formoterol. Eur Respir J 2011; 38: Suppl. 55, 833

Member's Comments

No comment yet.

Related content which might interest you: The effects of extrafine beclomethasone/formoterol on hyperinflation and airway geometry in COPD patients Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Efficacy of combined budesonide/formoterol delivered via turbuhaler on lung function and asthma control in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 496s Year: 2003 Reliever effect of extrafine BDP/F DPI in asthmatic patients after methacholine challenge Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Additional benefits of beclomethasone/formoterol extrafine combination treatment on small airways function in asthma Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009 Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 379s Year: 2004 Improved lung function and symptom control with formoterol on demand in asthma Source: Eur Respir J 2006; 27: 504-510 Year: 2006 HFA beclomethasone dipropionate (HFA-BDP) extrafine aerosol and formoterol in optimizing the management of bronchial asthma at children Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005 Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone Source: Eur Respir J 2001; 18: 262-268 Year: 2001 Reduction in air trapping and dyspnea with an extrafine combination of beclomethasone and formoterol in COPD Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010 Improved asthma control with budesonide/formoterol via a single inhaler, compared with budesonide alone, in moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 48s Year: 2001 Effects of budesonide/formoterol combination therapy versus budesonide on airway dimensions in asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma Source: Eur Respir J 2007; 29: 682-689 Year: 2007 Comparison of beclomethasone/formoterol and fluticasone/salmeterol fixed combinations for weekly asthma control Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Stable dosing with salmeterol/fluticasone propionate combination ensures long-term asthma control, including airway hyperresponsiveness Source: Eur Respir J 2005; 26: Suppl. 49, 429s Year: 2005 Lung function and symptom improvement with fluticasone/salmeterol and ipratropium/albuterol in albuterol responsive and non-responsive COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 Budesonide/formoterol in a single inhaler improves asthma control more effectively than a higher dose of fluticasone Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001 Efficiency of extrafine beclometasone dipropionat/formoterol fumarate in asthma patients with cold and/or osmotic airway hyperresponsiveness (AHR) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Budesonide and formoterol in a single inhaler quickly gains asthma control compared with fluticasone propionate in mild asthma Source: Eur Respir J 2001; 18: Suppl. 33, 48s Year: 2001 Efficacy of salmeterol/fluticasone pMDI versus DPI in patients with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006